Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study

  1. Allocca, M.
  2. Catalano, G.
  3. Savarino, E.V.
  4. Chaparro, M.
  5. Levartovsky, A.
  6. Michalopoulos, G.
  7. Viazis, N.
  8. Fousekis, F.S.
  9. Psistakis, A.
  10. Noviello, D.
  11. Nascimento, C.N.D.
  12. Caron, B.
  13. Kitsou, V.
  14. Bamias, G.
  15. García, M.J.
  16. Zacharopoulou, E.
  17. Foteinogiannopoulou, K.
  18. D'Amico, F.
  19. Koutroubakis, I.
  20. Ellul, P.
  21. Tzouvala, M.
  22. Peyrin-Biroulet, L.
  23. Torres, J.
  24. Caprioli, F.
  25. Karmiris, K.
  26. Theodoropoulou, A.
  27. Katsanos, K.H.
  28. Christodoulou, D.K.
  29. Mantzaris, G.J.
  30. Kopylov, U.
  31. Gisbert, J.P.
  32. Danese, S.
  33. Magro, F.
  34. Carla, F.
  35. Fiorino, G.
  36. Erakutsi egile guztiak +
Aldizkaria:
United European Gastroenterology Journal

ISSN: 2050-6414,  2050-6406

Argitalpen urtea: 2024

Mota: Artikulua

DOI: 10.1002/UEG2.12492 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus